Benchmark Issues Positive Forecast for IMAX (NYSE:IMAX) Stock Price

IMAX (NYSE:IMAXFree Report) had its price objective upped by Benchmark from $42.00 to $44.00 in a report issued on Thursday,Benzinga reports. They currently have a buy rating on the stock.

Other research analysts also recently issued reports about the stock. B. Riley Financial restated a “buy” rating on shares of IMAX in a research report on Monday, December 8th. JPMorgan Chase & Co. upgraded IMAX from a “neutral” rating to an “overweight” rating and lifted their price target for the company from $32.00 to $47.00 in a research note on Monday, December 15th. Macquarie Infrastructure upped their price objective on IMAX from $39.00 to $44.00 and gave the stock an “outperform” rating in a research report on Thursday, January 15th. Wedbush reiterated an “outperform” rating and issued a $46.00 target price on shares of IMAX in a research report on Monday. Finally, Weiss Ratings reissued a “buy (b)” rating on shares of IMAX in a report on Monday, December 29th. Ten investment analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $43.00.

Check Out Our Latest Report on IMAX

IMAX Stock Up 14.8%

Shares of IMAX stock opened at $41.92 on Thursday. IMAX has a 12-month low of $20.48 and a 12-month high of $42.46. The company has a market capitalization of $2.26 billion, a price-to-earnings ratio of 0.00, a PEG ratio of 1.81 and a beta of 0.38. The firm’s 50-day moving average price is $36.32 and its two-hundred day moving average price is $33.86.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of the stock. AQR Capital Management LLC lifted its holdings in IMAX by 47.9% during the 1st quarter. AQR Capital Management LLC now owns 56,348 shares of the company’s stock worth $1,485,000 after buying an additional 18,238 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its stake in shares of IMAX by 4.5% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 25,486 shares of the company’s stock worth $672,000 after acquiring an additional 1,091 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its stake in shares of IMAX by 7.9% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 159,714 shares of the company’s stock worth $4,208,000 after acquiring an additional 11,736 shares during the period. Y Intercept Hong Kong Ltd boosted its holdings in IMAX by 513.3% in the second quarter. Y Intercept Hong Kong Ltd now owns 47,108 shares of the company’s stock valued at $1,317,000 after acquiring an additional 39,427 shares during the last quarter. Finally, Bank of New York Mellon Corp increased its position in IMAX by 0.9% during the 2nd quarter. Bank of New York Mellon Corp now owns 267,331 shares of the company’s stock valued at $7,475,000 after purchasing an additional 2,343 shares during the period. 93.51% of the stock is owned by institutional investors.

Key Headlines Impacting IMAX

Here are the key news stories impacting IMAX this week:

  • Positive Sentiment: Q4 results beat expectations — EPS of $0.58 vs. $0.43 consensus and revenue of $125.2M (up 35% Y/Y); management posted improving margins and the quarter was buoyed by strong title performance. IMAX Q4 earnings beat — MarketBeat
  • Positive Sentiment: Record global box office in 2025 and bullish guidance — IMAX highlighted blockbuster tailwinds (notably the Avatar franchise) and outlined a $1.4B global box-office target for 2026, supporting revenue upside this year. Deadline: ‘Avatar’ lifts IMAX Q4
  • Positive Sentiment: Analyst upward revisions — JPMorgan raised its price target to $48 with an Overweight rating and Benchmark lifted its target to $44 with a Buy, giving additional near-term upside framing for the stock. Benzinga: Analyst price target updates TickerReport: Benchmark target raise
  • Positive Sentiment: Brokerage support reiterated — Rosenblatt and Wedbush reiterated buy/outperform stances, reinforcing institutional confidence after the quarter. Rosenblatt reiterates Buy
  • Positive Sentiment: Content slate and alternative events are expanding — Dune 3 secured IMAX opening-weekend exclusivity in many markets, Studio Ghibli’s Kiki re-release and live F1 broadcasts add non-traditional revenue streams and calendar diversity. Beebom: Dune 3 IMAX exclusivity Collider: Studio Ghibli IMAX re-release
  • Neutral Sentiment: The full Q4 earnings call transcript and slide deck are available for deeper detail on margin drivers and regional box-office cadence. Investors may want to review management commentary for guidance clarity. Seeking Alpha: Q4 earnings call transcript
  • Negative Sentiment: Limited IMAX exposure for a major tentpole in the U.S. — reports indicate Avengers: Doomsday will not play in IMAX on its opening weekend in the U.S., which could dent short-term domestic box-office contribution from that title. Gizmodo: Avengers not in IMAX opening weekend

IMAX Company Profile

(Get Free Report)

IMAX Corporation is a global leader in immersive entertainment technologies, specializing in the design, manufacture and distribution of high-resolution cameras, projectors, and proprietary software solutions that enhance both film production and theatrical exhibition. The company licenses its premium large-format system to theatre owners and filmmakers around the world, enabling audiences to experience movies with greater clarity, scale and sound fidelity. IMAX also offers turnkey theatre development services, assisting cinema operators with auditorium design, installation and custom branding to optimize the customer experience.

Founded in 1967 and headquartered in Mississauga, Ontario, IMAX has built a reputation for pioneering film-format innovations, including its patented dual 15-perforation, 70-millimeter projection system.

Further Reading

Analyst Recommendations for IMAX (NYSE:IMAX)

Receive News & Ratings for IMAX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IMAX and related companies with MarketBeat.com's FREE daily email newsletter.